Avril Biopharma
Avril Biopharma is a CDMO-focused biotechnology company developing bioinformatics-driven design tools and egg-based biomanufacturing platforms to enable rapid, low-cost production of recombinant proteins, vaccines and gene-based therapeutics. The organization emphasizes genomic analysis for design, vector-mediated expression in fertilized eggs for scalable manufacturing, and turnkey facility solutions to support distributed production and pandemic preparedness.
Industries
Nr. of Employees
small (1-50)
Avril Biopharma
Oakland, California, United States, North America
Products
Egg-based recombinant expression platform
Platform for expressing recombinant proteins and complex biopharmaceutical formats in fertilized eggs to support rapid small-batch production and linear scale-up to larger volumes.
Egg-based recombinant expression platform
Platform for expressing recombinant proteins and complex biopharmaceutical formats in fertilized eggs to support rapid small-batch production and linear scale-up to larger volumes.
Services
Genomic analysis, immunogenetic assessment and rational protein design to support vaccine, therapeutic and diagnostic development.
Vector-based expression in fertilized eggs for non-GMP research production, pilot GMP production, purification SOP development, stabilization and formulation.
Design, construction, certification and operational startup support for modular egg-based biomanufacturing facilities, including training and ongoing technical support.
Fee-for-service discovery, translational development and outsourced GLP/GMP manufacturing support for biologics, vaccines and gene-based products.
Genomic analysis, immunogenetic assessment and rational protein design to support vaccine, therapeutic and diagnostic development.
Vector-based expression in fertilized eggs for non-GMP research production, pilot GMP production, purification SOP development, stabilization and formulation.
Design, construction, certification and operational startup support for modular egg-based biomanufacturing facilities, including training and ongoing technical support.
Fee-for-service discovery, translational development and outsourced GLP/GMP manufacturing support for biologics, vaccines and gene-based products.
Expertise Areas
- CDMO services for biologics and vaccines
- Bioinformatics and genomic-driven design
- Egg-based biomanufacturing
- Vaccine and diagnostic development
Key Technologies
- Sequence-based bioinformatics
- Rational protein design
- Viral-vector-mediated expression
- Egg-based recombinant protein expression
News & Updates
Meeting and tour discussing outbreak response and how rapid protein expression services might support diagnostic and reagent production during an Ebola outbreak.
Panel presentation to raise awareness about Ebola and community response; participation by company leadership in public forums.
Support and participation in a community forum aimed at educating local communities about Ebola.
Meeting and tour discussing outbreak response and how rapid protein expression services might support diagnostic and reagent production during an Ebola outbreak.
Panel presentation to raise awareness about Ebola and community response; participation by company leadership in public forums.
Support and participation in a community forum aimed at educating local communities about Ebola.